Novo Nordisk A/S (NOV) Forecast & Analyst Ratings

XETR

Currency in EUR

34.32

-0.48 (-1.38%)

Real-time Data

07:00 AM

Day's Range

34.26

34.60

52 wk Range

30.23

54.87

Date	Firm	Action	Rating
Jul 26, 2024	Benchmark	Reiterates	Hold
Jan 16, 2024	Benchmark	Downgrade	Buy → Hold
Oct 02, 2023	Argus Research	Initiates coverage	Buy
Mar 28, 2023	BTIG	Maintains	Buy
Dec 12, 2022	TD Cowen	Maintains	Outperform
Jun 28, 2022	UBS	Downgrade	Neutral → Sell
Jun 07, 2022	JP Morgan	Upgrade	Neutral → Overweight
May 31, 2022	Guggenheim	Upgrade	Neutral → Buy
Mar 16, 2022	Deutsche Bank	Upgrade	Hold → Buy
Jan 25, 2022	Liberum	Downgrade	Hold → Sell

Items per row:

1-10 of 30

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

Period	Analysts	Low	Average	High	Year ago
Current quarter	-	-	-	-	-
Next quarter	-	-	-	-	-
Current year	-	-	-	-	-
Next year	-	-	-	-	-

Date	Time	EPS Estimate	EPS Actual	Difference	Surprise PRC
2026-05-05	After Hours	-	-	-	-
2026-02-03	After Hours	-	-	-	-
2026-01-17	After Hours	0.38	0.34	-0.04	‪-10.53%‬
2025-10-21	After Hours	2.10	2.24	+0.14	‪+6.67%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated: Oct 19, 2026, 07:00 AM

App Store